Bluejay Diagnostics, Inc. (BJDX) Financials

BJDX Assets vs Liabilities
DateAssetsLiabilities
Sept. 30, 2023 8.2 million 3.0 million
June 30, 2023 8.5 million 2.1 million
March 31, 2023 10.9 million 1.7 million
Dec. 31, 2022 13.5 million 2.0 million

BJDX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2023 -1.2 million -42483
June 30, 2023 -1.7 million 27704
March 31, 2023 -3.3 million 219589
Dec. 31, 2022 -3.2 million 87586

BJDX Net Income

No data available :(

BJDX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2023 5.1 million - 388809
June 30, 2023 5.1 million - 424019
March 31, 2023 6.8 million - 458619
Dec. 31, 2022 10.1 million - 508444

BJDX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2023 1.1 million
June 30, 2023 1.0 million
March 31, 2023 1.0 million
Dec. 31, 2022 1.0 million

BJDX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2023 74498 1.4 million 963534 19619
June 30, 2023 201105 1.7 million 1.1 million 154329
March 31, 2023 340669 1.4 million 1.2 million 148046
Dec. 31, 2022 238207 1.3 million 961888 170277

BJDX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2023 - 270785
June 30, 2023 - 293502
March 31, 2023 - 160345
Dec. 31, 2022 249040 68925

BJDX

Price: $4.51

52 week price:
1.62
16.68

Earnings Per Share: 657.48 USD

P/E Ratio: 0.01

Exchange: NCM

Sector: Healthcare

Industry: Medical Devices

Country: United States

Volume: 114300

Market Capitalization: 2.1 million

Links: